Rapid Update 3- April 2018: Respiratory: TRIBUTE study finds modest benefits of inhaled triple therapy on COPD exacerbations compared with dual bronchodilator therapy

This content is available to authorised users working in organisations that subscribe to ScriptSwitch only. Authorised users need to be logged in to read this content.

Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.

NPC Archive Item: Oral telaprevir▼ in patients with hepatitis C virus genotype 1 infection who did not have a sustained response to previous treatment

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 11 October 2011 The REALIZE trial (n = 663) found that the addition of oral telaprevir▼to standard therapy with peginterferon alfa-ribavirin was significantly more effective than standard treatment alone […]

NPC Archive Item: Once-weekly exenatide injection▼ launched in UK

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 2 September 2011 A once-weekly exenatide 2mg suspension for subcutaneous injection (Bydureon ▼®) has recently been launched for the management of type 2 diabetes. This prolonged- release formulation is […]